Ocular

RSS

Genetic basis for RP described

Feb. 5, 1998

FDA issues approvable letter for BioLon

Feb. 4, 1998

Novo Nordisk discloses peripheral muscarinic cholinergic agonists

Jan. 13, 1998

NIH contemplates licensing ophthalmic technology to GenVec

Jan. 7, 1998

Alcon discloses new antiglaucoma agents in patent literature

Jan. 2, 1998

Medarex's secondary cataract product enters phase III

Dec. 19, 1997

Pharmacyclics grants Alcon rights to Lu-Tex

Dec. 19, 1997

InSite Vision brings its once-daily glaucoma treatment to clinical trials

Dec. 8, 1997

Alcon compounds with dual antioxidant/cysteine prodrug properties

Dec. 8, 1997

Spotlight on carbonic anhydrase inhibitors for glaucoma

Nov. 25, 1997